During the past decade, Memorial Regional Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 19 clinical trials were completed, i.e. on average, 70.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Regional Hospital" #1 sponsor was "Pfizer" with 7 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Pharmacia" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Regional Hospital" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Medivation, Inc." with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator and "Canadian Heart Research Centre" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Regional Hospital" are "Coronary Artery Disease" (6 trials), "Breast Neoplasms" (4 trials), "HIV Infections" (4 trials), "Heart Failure" (4 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Memorial Regional Hospital" in a lesser frequency.

Most popular intervention types in "Memorial Regional Hospital" are "Drug" (36 trials), "Device" (15 trials), "Biological" (6 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Docetaxel" (5 trials), "Gemcitabine" (4 trials), "Nivolumab" (3 trials) and "Apixaban" (2 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Regional Hospital" are 51 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Regional Hospital". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Memorial Regional Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Regional Hospital, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 12 trials that are defined as “Not Applicable".